Home > Insider Trading > Filing (0001209191-15-030533)

Filing Details

Accession Number:: 0001209191-15-030533
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-03-31 20:38:18
Reporting Period:: 2015-03-27

Filing Date:: 2015-03-31
Accepted Time:: 2015-03-31 20:38:18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1510580	Kite Pharma Inc.	KITE	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1609805	Ran Nussbaum	C/O Kite Pharma, Inc. 2225 Colorado Avenue Santa Monica CA 90404		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-03-27	13,936	$61.24	216,064	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2015-03-27	13,937	$61.24	136,063	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2015-03-27	50,000	$61.24	70,000	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2015-03-30	66,948	$59.91	149,116	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2015-03-30	23,349	$59.91	112,714	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2015-03-30	25,560	$59.91	43,604	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Footnotes

The number of shares reflects the disposition of 846,390 shares in a pro-rata distribution from the partnership identified in Column 7 to its partners on March 27, 2015. In prior reports, the Reporting Person has reported all shares of the Issuer's common stock owned by the partnership.
The securities are held in the name of Pontifax (Cayman) II L.P.
The reporting person is a director of Pontifax Management 2 G.P. (2007) Ltd., the general partner of Pontifax (Cayman) II, L.P., Pontifax (Israel) II, L.P. and Pontifax (Israel) II - Individual Investors L.P.
The number of shares reflects the disposition of 660,803 shares in a pro-rata distribution from the partnership identified in Column 7 to its partners on March 27, 2015. In prior reports, the Reporting Person has reported all shares of the Issuer's common stock owned by the partnership.
The securities are held in the name of Pontifax (Israel) II, L.P.
The number of shares reflects the disposition of 194,743 shares in a pro-rata distribution from the partnership identified in Column 7 to its partners on March 27, 2015. In prior reports, the Reporting Person has reported all shares of the Issuer's common stock owned by the partnership.
The securities are held in the name of Pontifax (Israel) II - Individual Investors L.P.
The number of shares reflects the disposition of 836 shares in a pro-rata distribution from the partnership identified in Column 7 to its partners on March 30, 2015. In prior reports, the Reporting Person has reported all shares of the Issuer's common stock owned by the partnership.